bpi labs tirzepatide is challenging the patent. This is a second challenge as Empower pharmacy was already challenging the patent. BPI includes additional imformation including a previous patent application showing GLP-1/GIP as BPI Labs 40mg "Tall Boys".

Aminoguanidine, an iNOS inhibitor, was able to inhibit the formation of NO and interleukin-1-beta (IL-1) that was caused by this upregulation 147

Researchers are investigating retatrutide as a potential treatment for several metabolic conditions, including[2,3]: Type 2 diabetes Obesity Fatty liver disease Fatty liver disease is commonly linked to obesity, alcohol use, and diabetes

In this episode, Curt and I sit down with Robyn Goldberg to explore how clinicians can help clients build a healthier relationship with food and their bodieswhile also challenging bias and misinformation

Brand-name options may include Ozempic, Wegovy, Mounjaro, or Zepbound, depending on indication and availability

But what do we actually know about them